Organism: Homo sapiens, human

Cell Type: Human neural stem cell

Source: Foetal spinal cord at embryonic 50-55 days (Carnegie stage 19-22)

Datasheet: available under request


1. Sun Y, Pollard S, Conti L, Toselli M, Biella G, Parkin G, Willatt L, Falk A, Cattaneo E, Smith A. Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. Mol Cell Neurosci. 2008 Jun;38(2):245-58.

2. Sun Y, Kong W, Falk A, Hu J, Zhou L, Pollard S, Smith A. CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent.PLoS One. 2009;4(5):e5498.

3. Fujimoto Y, Abematsu M, Falk A, Tsujimura K, Sanosaka T, Juliandi B, Semi K, Namihira M, Komiya S, Smith A, Nakashima K. Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells. Stem Cells. 2012 Jun;30(6):1163-73.

4. Baronchelli SBentivegna ARedaelli SRiva GButta VPaoletta LIsimbaldi GMiozzo MTabano SDaga AMarubbi DCattaneo MBiunno IDalprà L. Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines. PLoS One 2013;8(2):e57462.